Myasthenia gravis and Fibrin d dimer increased

Summary:

Fibrin d dimer increased is found among people with Myasthenia gravis, especially for people who are female, 60+ old.

The study analyzes which people have Fibrin d dimer increased with Myasthenia gravis. It is created by eHealthMe based on reports of 11 people who have Myasthenia gravis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Myasthenia gravis?

Myasthenia gravis (a chronic condition that causes muscles to tire and weaken easily) is found to be associated with 544 drugs and 716 conditions by eHealthMe. Check the latest studies of Myasthenia gravis.

What is Fibrin d dimer increased?

Fibrin d dimer increased is found to be associated with 518 drugs and 836 conditions by eHealthMe. Check the latest studies of Fibrin d dimer increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

11 people who have Myasthenia Gravis and Fibrin D Dimer Increased are studied.

Would you have Fibrin d dimer increased when you have Myasthenia gravis?

Gender of people who have Myasthenia Gravis and experienced Fibrin D Dimer Increased *:

  • female: 54.55 %
  • male: 45.45 %

Age of people who have Myasthenia Gravis and experienced Fibrin D Dimer Increased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 20 %
  • 60+: 80 %

Common drugs taken by these people *:

  1. Lansoprazole: 4 people, 36.36%
  2. Soliris: 3 people, 27.27%
  3. Prograf: 3 people, 27.27%
  4. Triatec: 2 people, 18.18%
  5. Actonel: 2 people, 18.18%
  6. Aldactazide: 2 people, 18.18%
  7. Arimidex: 2 people, 18.18%
  8. Asacol: 2 people, 18.18%
  9. Eszopiclone: 2 people, 18.18%
  10. Lasix: 2 people, 18.18%

Common symptoms for these people *:

  1. Haematocrit Decreased: 3 people, 27.27%
  2. Stable Angina (a constant chest pain): 3 people, 27.27%
  3. Abdominal Pain: 2 people, 18.18%
  4. Po2 Decreased: 2 people, 18.18%
  5. Hepatitis Fulminant (life-threatening condition defined by significantly impaired liver function): 2 people, 18.18%
  6. Fibrin Degradation Products Increased: 2 people, 18.18%
  7. Dyspnea (difficult or laboured breathing): 2 people, 18.18%
  8. White Blood Cell Count Decreased: 2 people, 18.18%
  9. Joint Pain: 2 people, 18.18%
  10. Drug Level Increased: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Fibrin d dimer increased?

- Check whether Fibrin d dimer increased is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Fibrin d dimer increased:

All the conditions that are associated with Fibrin d dimer increased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Fibrin d dimer increased and Myasthenia gravis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: